- Home
- LEDS vs RLMD Comparison
LEDS vs RLMD Comparison
Compare LEDS & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LEDS
- RLMD
- Stock Information
- Founded
- LEDS 2005
- RLMD 2004
- Country
- LEDS Taiwan
- RLMD United States
- Employees
- LEDS N/A
- RLMD N/A
- Industry
- LEDS Semiconductors
- RLMD Biotechnology: Pharmaceutical Preparations
- Sector
- LEDS Technology
- RLMD Health Care
- Exchange
- LEDS Nasdaq
- RLMD Nasdaq
- Market Cap
- LEDS 13.8M
- RLMD 11.5M
- IPO Year
- LEDS 2010
- RLMD N/A
- Fundamental
- Price
- LEDS $2.45
- RLMD $0.66
- Analyst Decision
- LEDS
- RLMD Hold
- Analyst Count
- LEDS 0
- RLMD 4
- Target Price
- LEDS N/A
- RLMD $4.25
- AVG Volume (30 Days)
- LEDS 34.8K
- RLMD 2.1M
- Earning Date
- LEDS 04-10-2025
- RLMD 05-07-2025
- Dividend Yield
- LEDS N/A
- RLMD N/A
- EPS Growth
- LEDS N/A
- RLMD N/A
- EPS
- LEDS N/A
- RLMD N/A
- Revenue
- LEDS $14,780,000.00
- RLMD N/A
- Revenue This Year
- LEDS N/A
- RLMD N/A
- Revenue Next Year
- LEDS N/A
- RLMD N/A
- P/E Ratio
- LEDS N/A
- RLMD N/A
- Revenue Growth
- LEDS 160.76
- RLMD N/A
- 52 Week Low
- LEDS $0.92
- RLMD $0.24
- 52 Week High
- LEDS $2.94
- RLMD $4.47
- Technical
- Relative Strength Index (RSI)
- LEDS 60.10
- RLMD 76.27
- Support Level
- LEDS $1.80
- RLMD $0.27
- Resistance Level
- LEDS $2.31
- RLMD $0.70
- Average True Range (ATR)
- LEDS 0.20
- RLMD 0.06
- MACD
- LEDS 0.00
- RLMD 0.04
- Stochastic Oscillator
- LEDS 74.67
- RLMD 82.12
About LEDS SemiLEDS Corporation
SemiLEDs Corp develops, manufactures, and sells light-emitting diode chips and LED components. The company's products include LED Chips, LED Components, and Lighting Products. Its products are used for general lighting applications, including street lights and commercial, industrial, system, and residential lighting; specialty industrial applications, such as ultraviolet, or Ultraviolet, curing of polymers, LED light therapy in medical/cosmetic applications, counterfeit detection, LED lighting for horticulture applications, architectural lighting and entertainment lighting. Substantial revenue is generated from the sale of LED components products. Geographically, it derives a majority of its revenue from Japan.
About RLMD Relmada Therapeutics Inc.
Relmada Therapeutics Inc is a clinical-stage biotechnology company. It is engaged in developing chemical entities with novel versions of drug products that address areas of high unmet medical need in the treatment of central nervous system diseases. The company is focused on the development of esmethadone (d-methadone, dextromethadone, REL-1017), an N-methyl-D-aspartate (NMDA) receptor antagonist. Its lead product candidate, esmethadone, is an oral agent for the treatment of depression and other potential indications.